ANXA2 and cancer: The cell surface associated AnxA2 heterotetramer, is a receptor for both plasminogen and tissue type plasminogen activator (tPA) and acts as a catalytic center for the activation of plasminogen to plasmin [27], [28] which helps in invasion and metastasis of cancer cells [18], [27].